Kyverna Therapeutics KYTX
NASDAQ KYTX
$5.84 -0.01 (-0.09%)
As of: Oct 22, 2026 · 10:57 AM EDT

Kyverna Therapeutics (KYTX) Total Non-Current Liabilities (2024)

Updated

Kyverna Therapeutics (KYTX) posted Total Non-Current Liabilities of $36.19 million for Q3 2024.

Analysis

Kyverna Therapeutics (KYTX) Total Non-Current Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn 106.45 Bn
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn 33.91 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn 35.10 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn 97.04 Bn
10 Kyverna Therapeutics 357.16 Mn -529.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 36.19 Mn
API Access

Kyverna Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KYTX&period=max&api_key=YOUR_API_KEY